Neurable is a Boston-based neurotechnology company building non-invasive brain-computer interfaces (BCIs) that fit inside everyday consumer hardware. Its AI cleans and interprets EEG brain signals captured by soft sensors embedded in products like the MW75 Neuro headphones, translating brain activity into real-time measures of focus, mental fatigue and cognitive recovery. Spun out of University of Michigan research, Neurable aims to make understanding your own brain as natural as checking your step count - starting with headphones and expanding into gaming and enterprise wearables.
Attune Neurosciences is a San Francisco-based, clinical-stage medical device company building what it calls the first wearable, non-invasive focused-ultrasound system for deep brain therapy. Its investigational headband, ATTN201, uses low-intensity transcranial focused ultrasound (tFUS) to reach precise deep-brain targets - like the central medial thalamus - while recording EEG and head movement, aiming to treat sleep and wake disorders, depression, addiction recovery, and other neurological and psychiatric conditions without drugs or surgery.
Rarebird is a New York and San Leandro-based specialty coffee company that replaces caffeine with paraxanthine (Px), the natural metabolite your body turns caffeine into. Founded by bioengineer Dr. Jeffrey Dietrich, Rarebird uses a patented reverse-infusion process to load 60mg of Px into single-origin Colombian decaf beans, promising alertness and focus without the jitters, anxiety, cortisol spikes, or wrecked sleep. Backed by Y Combinator, AgFunder, First Round Capital and the National Science Foundation, Rarebird is trying to make Px 'the third coffee' - a category alongside regular and decaf.